)
Visual
earnings real time
Sartorius Stedim Biotech
Sartorius Stedim Biotech (DIM) investor relations material
Sartorius Stedim Biotech Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary3 Feb, 2026
Executive summary
Achieved and exceeded FY 2025 guidance with strong revenue and margin growth, led by recurring consumables and improved operational performance across both divisions.
Margin expansion was driven by scale, favorable product mix, and occurred despite FX and US tariff headwinds.
Operational improvements enabled deleveraging and reinforced a strong balance sheet.
Strategic investments in innovation, sustainability, and global capacity expansion position the company for sustainable, innovation-led growth.
Confident outlook for 2026, expecting continued growth and profitability.
Financial highlights
Sales revenue increased by 9.6% in constant currencies (7.6% in some reports), reaching over €3.5 billion, with Bioprocess Solutions up 9.5% and Lab Products & Services up 0.2%.
Underlying EBITDA rose 17.3% to €1.052 billion, margin expanding to 30.8%–29.7%.
Underlying net profit grew 18%–26.7%, reported net profit up 51.7%–84%, and underlying EPS increased to €4.78.
Operating cash flow was €837 million; free cash flow ranged from €295 million to €390 million.
Equity ratio improved to 39.8%–51.7%; leverage ratio (net debt/EBITDA) improved to 2.38–3.55x.
Outlook and guidance
2026 group sales growth expected at 5%–10% in constant currencies, with EBITDA margin slightly above 30%.
BPS sales growth forecast at 6%–10%, with margin slightly above 32%; LPS sales growth at 2%–6%, margin slightly below 21%.
CapEx ratio to remain around 12.5%–13.3%; leverage ratio to decrease to slightly above 2–3x.
Guidance reflects ongoing macroeconomic, industry-specific, and geopolitical volatility, with a broad range to reflect uncertainty.
Guidance excludes potential additional US tariffs.
Impact of new process intensification systems?
Strategic rationale for global infrastructure expansion?
Key factors influencing 2026 guidance uncertainty?
When will equipment demand fully normalize?
LPS margin recovery timeline?
What drives China's early recovery signs?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- WOSG
Q3 sales growth exceeded expectations, guidance raised, and US presence expanded. - NOBA
Record profit growth, robust capital, and SME expansion drive strong 2025 results. - SF
Margins expanded to 27% despite revenue decline and large non-cash impairments. - IFX
Q1 FY26 revenue up 7% YoY to €3.66bn, led by AI and automotive, with key acquisition and investments. - WRT1V
All-time high profit and cash flow, with robust Marine and Energy growth and major investments. - CB
Record net income and strong underwriting drive robust growth, with positive 2026 outlook. - BERG
EBITA and margins rose 12% with 4% organic growth, supported by acquisitions and efficiency. - APOTEA
Full-year revenue up 10.1%, but Q4 margin dropped to 1.3% on higher costs. - V2RETAIL
Q3 and 9M FY26 saw strong revenue and profit growth, aided by expansion and lease gains. - SECU
8% margin reached, 4% organic growth, and digital risk intelligence expansion underway.
Next Sartorius Stedim Biotech earnings date
Q1 202623 Apr, 2026
Sartorius Stedim Biotech
Next Sartorius Stedim Biotech earnings date
Q1 202623 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Sartorius Stedim Biotech S.A. is a global supplier of biopharmaceutical equipment and services, specializing in the development of products used in the manufacture of vaccines, biologics, and cell-based therapies. The company offers a wide range of solutions, including bioreactors, filtration systems, and single-use technologies, aimed at optimizing and accelerating biopharmaceutical production processes. The company is headquartered in Aubagne, France, and its shares are listed on Euronext Paris.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage